Literature DB >> 14630997

Receptor-controlled phosphorylation of alpha 1 soluble guanylyl cyclase enhances nitric oxide-dependent cyclic guanosine 5'-monophosphate production in pituitary cells.

Tatjana S Kostic1, Silvana A Andric, Stanko S Stojilkovic.   

Abstract

It is generally accepted that G protein-coupled receptors stimulate soluble guanylyl cyclase (sGC)-mediated cGMP production indirectly, by increasing nitric oxide (NO) synthase activity in a calcium- and kinase-dependent manner. Here we show that normal and GH(3) immortalized pituitary cells expressed alpha(1)beta(1)-sGC heterodimer. Activation of adenylyl cyclase by GHRH, pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal peptide, and forskolin increased NO and cGMP levels, and basal and stimulated cGMP production was abolished by inhibition of NO synthase activity. However, activators of adenylyl cyclase were found to enhance this NO-dependent cGMP production even when NO was held constant at basal levels. Receptor-activated cGMP production was mimicked by expression of a constitutive active protein kinase A and was accompanied with phosphorylation of native and recombinant alpha(1)-sGC subunit. Addition of a protein kinase A inhibitor, overexpression of a dominant negative mutant of regulatory protein kinase A subunit, and substitution of Ser(107)-Ser(108) N-terminal residues of alpha(1)-subunit with alanine abolished adenylyl cyclase-dependent cGMP production without affecting basal and NO donor-stimulated cGMP production. These results indicate that phosphorylation of alpha(1)-subunit by protein kinase A enlarges the NO-dependent sGC activity, most likely by stabilizing the NO/alpha(1)beta(1) complex. This is the major pathway by which adenylyl cyclase-coupled receptors stimulate cGMP production.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14630997     DOI: 10.1210/me.2003-0015

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  7 in total

Review 1.  Ion channels and signaling in the pituitary gland.

Authors:  Stanko S Stojilkovic; Joël Tabak; Richard Bertram
Journal:  Endocr Rev       Date:  2010-07-21       Impact factor: 19.871

2.  Thrombospondin-1 and angiotensin II inhibit soluble guanylyl cyclase through an increase in intracellular calcium concentration.

Authors:  Saumya Ramanathan; Stacy Mazzalupo; Scott Boitano; William R Montfort
Journal:  Biochemistry       Date:  2011-08-16       Impact factor: 3.162

3.  Cannabinoid receptor-mediated translocation of NO-sensitive guanylyl cyclase and production of cyclic GMP in neuronal cells.

Authors:  Jenelle D Jones; Skyla T Carney; Kent E Vrana; Derek C Norford; Allyn C Howlett
Journal:  Neuropharmacology       Date:  2007-07-12       Impact factor: 5.250

4.  Protein kinase G phosphorylates soluble guanylyl cyclase on serine 64 and inhibits its activity.

Authors:  Zongmin Zhou; Nazish Sayed; Anastasia Pyriochou; Charis Roussos; David Fulton; Annie Beuve; Andreas Papapetropoulos
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07-17       Impact factor: 8.311

Review 5.  Concepts of neural nitric oxide-mediated transmission.

Authors:  John Garthwaite
Journal:  Eur J Neurosci       Date:  2008-06       Impact factor: 3.386

6.  Dependence of Leydig Cell's Mitochondrial Physiology on Luteinizing Hormone Signaling.

Authors:  Marija L J Medar; Dijana Z Marinkovic; Zvezdana Kojic; Alisa P Becin; Isidora M Starovlah; Tamara Kravic-Stevovic; Silvana A Andric; Tatjana S Kostic
Journal:  Life (Basel)       Date:  2020-12-31

Review 7.  The role of cyclic nucleotides in pituitary lactotroph functions.

Authors:  Marek Kucka; Ivana Bjelobaba; Melanija Tomić; Stanko S Stojilkovic
Journal:  Front Endocrinol (Lausanne)       Date:  2013-09-13       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.